Zhe Li (Joanne)

Zhe (Joanne) Li is a Principal Scientist at Allogene Therapeutics, where the focus is on developing allogeneic CAR-T therapies for solid tumors since June 2021. Prior to this role, Zhe served as an NIH T32 Postdoctoral Fellow at UCLA, under Dr. Lili Yang, working on stem cell engineered cell products for cancer immunotherapy and investigating molecular control of antitumor immunity. Zhe also has experience as a Graduate Research Assistant at the University of Southern California, completing a Ph.D. in Pharmaceutical Sciences in 2018, and as a Research Intern at Genentech, where genetic modifications of stem cells were performed. Zhe began academic pursuits in biology at Peking University, earning a Bachelor’s Degree in 2012.